GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exelixis Inc (FRA:EX9) » Definitions » Total Tax Payable

Exelixis (FRA:EX9) Total Tax Payable : €0 Mil (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Exelixis Total Tax Payable?

Exelixis's Total Tax Payable for the quarter that ended in Sep. 2024 was €0 Mil.

Exelixis Total Tax Payable Historical Data

The historical data trend for Exelixis's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exelixis Total Tax Payable Chart

Exelixis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Exelixis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Exelixis Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Exelixis Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Exelixis's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Exelixis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exelixis Inc (FRA:EX9) » Definitions » Total Tax Payable
Comparable Companies
RVMD SRPT PCVX ROIV TECH RPRX BMRN ASND JAZZ MDGL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
EXEL:USA 0IJO:UK EX9:Germany
Address
1851 Harbor Bay Parkway, Alameda, CA, USA, 94502
Website
https://www.exelixis.com
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis Headlines

No Headlines